Table 1.

Characteristics of patients who developed HZ at initiation of baricitinib

DLTSeliciclib dose (mg)Doses receivedContributing AEsContributing SAEsDescriptionOutcomeA
1400830Constipation, N+V, liver injury; fatigue.Resolved
2600430Constipation, N+V.Resolved
3600101BFever, N+V, renal injury.Resolved
4400831BConstipation, N+V, jaundice, liver injury.Resolved
5400840Fever, dizziness, liver injury.Resolved
6400890Dizziness, N+V, liver injury, bilirubin rise.Persistent AST rise